Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option

Atrial fibrillation (AF) is the most common sustained arrhythmia with a prevalence of up to 4% and an upwards trend due to demographic changes. It is associated with an increase in mortality and stroke incidences. While stroke risk can be significantly reduced through anticoagulant therapy, adequate...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Kraft, Manuel, Büscher, Antonius, Wiedmann, Felix, L’hoste, Yannick, Haefeli, Walter E., Frey, Norbert, Katus, Hugo A., Schmidt, Constanze
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8058608/
https://ncbi.nlm.nih.gov/pubmed/33897427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.638445
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki